Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

FlixMobility books $561m series F

FlixMobility has raised a reported $561m in series F funding co-led by TCV and Permira, securing capital for the first time since a Daimler-backed round in 2016.

Medicxi prescribes $450m fund

Novartis, Johnson & Johnson, Verily and GSK have all returned for Medicxi’s latest fund that brought the firm’s total assets under management to more than $1bn.


GCV Synergize 2019
25th September 2019
GCV Energy 2019
21st November 2019
GCVI Summit 2020
29th January 2020
ZhongAn rakes in $285m funding round
ZhongAn invested $145m into its fintech-focused unit as part of a $285m funding round that also featured Sinolink Worldwide.
Sierra calls in corporates for $215m fund
Venture capital firm Sierra Ventures has received LP commitments from several undisclosed corporates to reach a $215m close.
Kronos cracks $105m series A
GV contributed to a round for MIT-founded small molecule cancer drug spinout Kronos Bio, adding to $18m raised by the latter 14 months ago.
Phressia engages with public markets
Phreesia has raised more than $167m in proceeds after pricing shares above its range at $18, providing exits to BlueCross BlueShield, Ascension Health and Echo Health Ventures.
Mirum processes $75m IPO
Mirum Pharmaceuticals has raised $75m in its initial public offering that had an initial target of $86.3m and provided exits to Novo and Shire.
Fulcrum fulfils IPO dream
GlaxoSmithKline, Sanofi and 6 Dimensions Capital have all secured exits as the rare disease treatment developer raised $72m in its initial public offering.
test reg